Facebook Linkedin RSS Twitter Youtube
Home 2024

X-linked genetic diseases

Novartis Buys Kate Therapeutics, Expanding in Neuro Gene Therapy
Drug Discovery

Novartis Buys Kate Therapeutics, Expanding in Neuro Gene Therapy

Gene Therapy for Muscular Dystrophy Could Use StitchR to Assemble XL Gene from S Segments
Genome Editing

Gene Therapy for Muscular Dystrophy Could Use StitchR to Assemble XL Gene from S Segments

PAMless Base Editors Correct X-CGD Mutation Efficiently and Precisely
Genome Editing

PAMless Base Editors Correct X-CGD Mutation Efficiently and Precisely

Digital Twins of Biological Systems Inform Drug Development
Drug Discovery

Digital Twins of Biological Systems Inform Drug Development

New Computational Model Matches Drugs to Protein Synthesis Disruptors in Hereditary Diseases, Cancer
Cancer

New Computational Model Matches Drugs to Protein Synthesis Disruptors in Hereditary Diseases, Cancer

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data
Drug Discovery

StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data

StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares
GEN Edge

StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
GEN Edge

StockWatch: “Final Resolution” Set for Illumina’s Grail Saga

ASGCT 2024: Interview with Frédéric Revah, CEO of Généthon
Artificial Intelligence

ASGCT 2024: Interview with Frédéric Revah, CEO of Généthon

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress
Genome Editing

ASGCT 2024: Kate Therapeutics Unveils Gene Therapy Platform and Product Pipeline Progress

123...20Page 1 of 20
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.